Rekha Gupta-led Delhi govt introduces draft EV policy, earmarks nearly Rs 4,000 crore
98 km, 85 minutes, one life saved: Live heart rushed from Rohtak to Delhi for transplant
Asha Bhosle suffers cardiac arrest, admitted to Breach Candy Hospital in Mumbai
IPL 2026: Sanju Samson scripts unique CSK record, achieves feat MS Dhoni never managed
Shashi Tharoor rebukes Pakistan's role in US-Iran peace talks: 'Only they can play that role'
'Iran is losing big': Donald Trump makes big claims in latest post amid peace talks
‘Train your replacements’: Woman shares ‘humiliating’ post after being fired from company
Who is Aradhana Das? IAS officer accused of cheating man of Rs 95 lakh, issuing death threats
INDIA
)
In a major boost to India's fight against COVID-19, the Subject Expert Committee (SEC) has given a recommendation to the Drugs Controller General of India (DCGI) for the use of Bharat Biotech's Covaxin for 2 to 18-year-olds.